Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® . Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic® AETOSWire 12 February، 2024 into the Saudi, Jordanian and Iraqi Markets Amman, Jordan Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has... Read More Read more about Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®
